Cargando…
PSAT373 Metformin Decreases Serum Thyroglobulin Concentration in Non-Medullary Thyroid Carcinoma
BACKGROUND: The conventional treatment of non-medullary thyroid carcinoma (NMTC) includes surgical resection, TSH suppression and 131-iodine. Although highly successful, some patients develop persistent/recurrent NMTC requiring alternative therapies, including external radiation and multikinase inhi...
Autores principales: | Caetano, Celina, Pico, Paola Tabaro, Singh, Charan, Molina, Marco, Tendler, Beatriz, Malchoff, Diana M, Malchoff, Carl D |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9627754/ http://dx.doi.org/10.1210/jendso/bvac150.1743 |
Ejemplares similares
-
Metformin Decreases Serum Thyroglobulin Concentration in Nonmedullary Thyroid Carcinoma
por: Caetano, Celina, et al.
Publicado: (2022) -
SUN-LB84 Riedel’s Thyroiditis: A Diagnostic and Therapeutic Challenge
por: Sliwinska, Aleksandra, et al.
Publicado: (2020) -
PSAT384 Familial Non-Medullary Thyroid Cancer — Does The Number Of Alanine Residues In The FOXE1 Gene Play A Role?
por: Trofimiuk-Muldner, Malgorzata, et al.
Publicado: (2022) -
PSAT387 An Unusual Case of Sporadic Metastatic Medullary Thyroid Cancer Without a Primary Tumor Presenting with Paraneoplastic Cushing's Syndrome
por: Jumani, Sanjay, et al.
Publicado: (2022) -
Utility of Stimulated Thyroglobulin in the Differentiate Thyroid Cancer
por: Romero, Fabiola, et al.
Publicado: (2021)